United Therapeutics Corp Files 8-K
Ticker: UTHR · Form: 8-K · Filed: Aug 1, 2025 · CIK: 1082554
| Field | Detail |
|---|---|
| Company | United Therapeutics Corp (UTHR) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-disclosure
Related Tickers: UNTH
TL;DR
UNTH filed an 8-K on Aug 1, 2025, likely a material agreement.
AI Summary
On August 1, 2025, United Therapeutics Corporation entered into a material definitive agreement. The filing also includes information regarding Regulation FD disclosure and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Silver Spring, Maryland.
Why It Matters
This 8-K filing indicates a significant corporate event or agreement for United Therapeutics Corporation, requiring disclosure to the public.
Risk Assessment
Risk Level: low — This is a standard 8-K filing reporting a material definitive agreement, which is routine corporate disclosure.
Key Numbers
- 000-26301 — SEC File Number (Identifies the company's filing history with the SEC.)
- 52-1984749 — IRS Employer Identification Number (Unique identifier for tax purposes.)
Key Players & Entities
- United Therapeutics Corporation (company) — Registrant
- August 1, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Silver Spring, MD (location) — Principal Executive Offices
FAQ
What type of material definitive agreement did United Therapeutics Corporation enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on August 1, 2025.
What is the primary business of United Therapeutics Corporation?
United Therapeutics Corporation is in the Pharmaceutical Preparations industry, SIC code 2834.
When is United Therapeutics Corporation's fiscal year end?
The company's fiscal year ends on December 31.
What is the address of United Therapeutics Corporation's principal executive offices?
The principal executive offices are located at 1000 Spring Street, Silver Spring, MD 20910.
What other items are included in this 8-K filing besides the material definitive agreement?
This 8-K filing also includes information on Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 1, 2025 regarding UNITED THERAPEUTICS Corp (UTHR).